| Product Name |
Recombinant Human Coagulation Factor XIII B chain / F13B Protein |
| Product Overview |
This recombinant human Coagulation Factor XIII B chain / F13B protein includes amino acids 1-661aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id |
P05160 |
| Recommended Name |
Coagulation factor XIII B chain |
| Gene Name |
F13B |
| Synonyms |
Coagulation factor 13;Coagulation factor XIII;FXIIIB |
| Species |
Human |
| Predicted Molecular Mass |
74.5 kDa |
| Expression System |
Mammalian Cell |
| Expression Range |
1-661aa |
| Tag |
C-His |
| Purity |
>90% |
| Formulation |
Lyophilized |
| Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area |
Cardiovascular |
| Target Function |
The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. |
| Subcellular Location |
Secreted. |
| Associated Diseases |
Factor XIII subunit B deficiency (FA13BD) |
